Ar. Marcotegui et al., DEOXYPYRIDINOLINE AND OTHER BIOCHEMICAL M ARKERS OF BONE-RESORPTION IN DIFFERENT CONDITIONS, Revista Clinica Espanola, 197(6), 1997, pp. 389-392
Collagen type 1 represents more than 90% of bone matrix. Therefore, qu
antitation of collagen crosslinks, such as deoxypyridinoline, can prov
ide information on bone resorption degree. An evaluation was made of d
eoxypyridinoline as well as other bone markets, such as alkaline phosp
hatase, tartrate resistant acid phosphatase, and hydroxyproline in pat
ients with the diagnosis of osteoporosis, Paget's disease, hyperthyroi
dism, and chronic renal failure on haemodyalisis or not. Deoxypyridino
line levels were significantly increased in patients with osteoporosis
, Paget's disease, and hyperthyroidism. Hydroxyproline levels were inc
reased in patients with Paget's disease, and tartrate resistant acid p
hosphatase was increased in all the entities studied. Deoxypyridinolin
e can be a more sensitive marker than hydroxyproline, with some advant
ages, such as its quantitation in a urine specimen and its high bone s
pecificity. In patients with renal failure, tartrate resistant acid ph
osphatase was the only biochemical marker of bone resorption with incr
eased levels.